UnitedHealth Group Inc. (UNH) Upgraded to “Buy” at Vetr Inc.
UnitedHealth Group Inc. (NYSE:UNH) was upgraded by equities researchers at Vetr to a “buy” rating in a note issued to investors on Friday.
A number of other analysts have also recently commented on the company. Leerink Swann reissued an “outperform” rating on shares of UnitedHealth Group in a research report on Sunday, August 21st. Sanford C. Bernstein reissued an “outperform” rating and issued a $178.00 price target on shares of UnitedHealth Group in a research report on Tuesday, September 6th. Royal Bank Of Canada boosted their price target on UnitedHealth Group from $157.00 to $165.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 20th. Credit Suisse Group AG restated a “buy” rating and issued a $148.00 price objective on shares of UnitedHealth Group in a report on Wednesday, June 29th. Finally, Zacks Investment Research lowered shares of UnitedHealth Group from a “hold” rating to a “sell” rating in a report on Monday, July 18th. One equities research analyst has rated the stock with a hold rating, twenty-five have assigned a buy rating and one has issued a strong buy rating to the stock. UnitedHealth Group presently has a consensus rating of “Buy” and a consensus target price of $155.35.
Shares of UnitedHealth Group (NYSE:UNH) traded up 0.14% during trading on Friday, reaching $136.66. The company’s stock had a trading volume of 2,568,703 shares. The company has a market capitalization of $130.15 billion, a price-to-earnings ratio of 21.39 and a beta of 0.57. UnitedHealth Group has a one year low of $107.51 and a one year high of $144.48. The firm’s 50-day moving average price is $137.80 and its 200-day moving average price is $136.35.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/07/unitedhealth-group-inc-unh-upgraded-to-buy-at-vetr-inc-2.html
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 19th. The healthcare conglomerate reported $1.96 EPS for the quarter, topping analysts’ consensus estimates of $1.89 by $0.07. UnitedHealth Group had a return on equity of 19.08% and a net margin of 3.51%. The firm had revenue of $46.50 billion for the quarter, compared to analysts’ expectations of $45.05 billion. On average, equities analysts anticipate that UnitedHealth Group will post $7.90 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 20th. Stockholders of record on Friday, September 9th were given a dividend of $0.625 per share. This represents a $2.50 annualized dividend and a dividend yield of 1.83%. The ex-dividend date of this dividend was Tuesday, September 6th. UnitedHealth Group’s dividend payout ratio is 39.12%.
In other news, Director Richard T. Burke sold 40,000 shares of the company’s stock in a transaction dated Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total transaction of $5,412,400.00. Following the sale, the director now directly owns 2,003,550 shares in the company, valued at approximately $271,100,350.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 1.65% of the company’s stock.
Several hedge funds have recently made changes to their positions in UNH. Filament LLC acquired a new stake in shares of UnitedHealth Group during the third quarter valued at about $490,000. Catawba Capital Management VA boosted its stake in shares of UnitedHealth Group by 7.1% in the third quarter. Catawba Capital Management VA now owns 3,765 shares of the healthcare conglomerate’s stock valued at $527,000 after buying an additional 250 shares in the last quarter. Bremer Trust National Association boosted its stake in shares of UnitedHealth Group by 64.8% in the third quarter. Bremer Trust National Association now owns 24,538 shares of the healthcare conglomerate’s stock valued at $3,435,000 after buying an additional 9,649 shares in the last quarter. Liberty Capital Management Inc. boosted its stake in shares of UnitedHealth Group by 2.3% in the third quarter. Liberty Capital Management Inc. now owns 10,654 shares of the healthcare conglomerate’s stock valued at $1,471,000 after buying an additional 235 shares in the last quarter. Finally, Independent Portfolio Consultants Inc. boosted its stake in shares of UnitedHealth Group by 531.3% in the third quarter. Independent Portfolio Consultants Inc. now owns 1,010 shares of the healthcare conglomerate’s stock valued at $141,000 after buying an additional 850 shares in the last quarter. Hedge funds and other institutional investors own 85.78% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
To view Vetr’s full report, visit Vetr’s official website.
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.